We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

2 dull but delightful stocks I’d back to keep growing dividends

Our writer would rather back boring-but-consistent dividend growth stocks over those offering above-average amounts of passive income.

| More on:
British coins and bank notes scattered on a surface

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

The best dividend stocks to buy for passive income share two qualities, in my opinion. First, they regularly churn out a nice (but not excessive) amount of cash to investors. Second, they possess great records of growing these payouts every (or nearly every) year.

In my experience, many of those that tick both of these boxes tend to be pretty boring companies. And that’s just fine with me! Consistency is the goal here, not excitement.

Should you buy Bodycote Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Let’s look at a couple I’d consider buying if creating a second income was my primary goal.

Reliable payer

Bodycote‘s (LSE: BOY) one example of a business I’d back to keep raising its cash payouts going forward. Why? Because this FTSE 250-listed heat treatment and thermal processing services provider has build up an excellent record of doing just that over many years. There’s even been the odd special dividend along the way.

Of course, just because a company’s thrown money at its investors in the past doesn’t guarantee it will continue to do so, especially if trading takes a knock.

Bodycote’s no exception. It’s worth being aware that recent interim results for the first six months of 2024 mentioned “challenging” market conditions for its Automotive and General Industrial (AGI) division. As a result, the company’s needed to take “a number of decisive actions to balance costs and capacity with near-term demand“.

Don’t get greedy

On a more positive note, the firm made no change to its full-year outlook. This makes me think the 3.7% dividend yield looks safe. In fact, analysts suspect the payout will be covered over twice by expected profit.

Some may scoff at such an average yield when there are other companies offering nearly triple that. But I’d rather receive a lower but rising payout than never receive a higher one. What looks too good to be true often is.

5% yield

Fellow FTSE 250-listed wealth manager Rathbones (LSE: RAT) is another deadly dull dividend demon that’s been increasing the money it returns to investors for donkey’s years.

I find this impressive, not least because it operates in a sector where sentiment can quickly change depending on macro-economic headlines. A smidgen over 5%, the dividend yield’s also chunky and looks likely to be covered comfortably by profit.

One potential fly in the ointment is last year’s merger with Investec Wealth & Management. Although this seems to have gone well, it may take a bit more time to truly judge whether this move was truly in the interest of shareholders.

Cheap to buy

Still, it’s not like the valuation looks stretched. The shares currently change hands for a very reasonable 11 times expected FY24 earnings. That might even turn out to be a bargain in time if July’s interim results are anything to go by.

In a sign that risk appetite’s recovering, Rathbones reported a 3.4% rise in its funds under management and administration for the first six months of 2024.

If and when confidence returns en masse — perhaps after a succession of interest rate cuts both here and in the US — I wonder if I might see a nice positive gain on top of those dividend payments if I were to buy now.

Paul Summers has no position in any of the shares mentioned. The Motley Fool UK has recommended Bodycote Plc and Rathbones Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Up nearly 1,400% in 5 years! But are Rolls-Royce shares still secretly undervalued?

After skyrocketing, Rolls-Royce shares are now near an all-time high, but could the engineering giant still have more room to…

Read more »

Happy senior couple hugging and enjoying retirement at home
Investing Articles

By mid-2027, analysts expect £5,000 in Barclays shares to be worth…

Barclays shares have outperformed the FTSE 100 by a wide margin over the last year. And City analysts expect to…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Near 5-year lows, here’s what the experts say about the Diageo share price

Ben McPoland's questioning his sanity after investing in Diageo. Where do institutional analysts see its share price heading over the…

Read more »

British Airways cabin crew with mobile device
Investing Articles

Up 165% but still with a P/E of 7.9. Is the IAG share price a generational bargain?

The IAG share price has been on fire for the last two years, delivering some of the biggest returns in…

Read more »

Emma Raducanu for Vodafone billboard animation at Piccadilly Circus, London
Investing Articles

Here’s the latest Vodafone share price forecasts for 2027

Up 35% in 12 months, the Vodafone share price is beating the stock market right now, but can this momentum…

Read more »